期刊文献+

纤维电子喉镜辅助下肉毒毒素A治疗内收型痉挛性发音障碍 被引量:2

原文传递
导出
摘要 痉挛性发音障碍是一种扰乱声带正常运动,在发音时引起喉部肌肉异常痉挛的局灶性喉肌肌张力障碍,系中枢运动信息处理程序障碍所致的慢性神经系统疾病^[1]。文献报道发生率低于1/100000,女性稍多。可分为内收型、外展型及,
出处 《中华耳鼻咽喉头颈外科杂志》 CAS CSCD 北大核心 2012年第7期601-602,共2页 Chinese Journal of Otorhinolaryngology Head and Neck Surgery
  • 相关文献

参考文献16

  • 1胡兴越,范正刚,蒋红,章士正,邵宇权.A型肉毒毒素治疗痉挛性发音障碍[J].中华耳鼻咽喉科杂志,2002,37(6):466-467. 被引量:8
  • 2Blitzer A, Brin MF, Stewart CF. Botulinum toxin management of spasmodic dysphonia (laryngeal dystonia) : a 12-year experience in more than 900 patients. Laryngoscope, 1998, 108: 1435-1441.
  • 3Blitzer A, Brin MF, Fahn S, et al. Botulinum toxin (BOTOX) for the treatment of "spastic dysphonia" as part of a trial of toxin injections for the treatment of other cranial dystonias. Laryngoscope, 1986, 96: 1300-1301.
  • 4Ludlow CL. Spasmodic dysphonia: a laryngeal control disorder specific to speech. J Neurosei, 2011, 31 : 793-797.
  • 5杨扬,王丽萍.内收型痉挛性发音障碍的语音特征[J].中华耳鼻咽喉头颈外科杂志,2008,43(6):419-423. 被引量:5
  • 6Dedo HH. Recurrent laryngeal nerve section for spastic dysphonia. Ann Otol Rhinol Laryngol, 1976, 85 : 451-459.
  • 7Aronson AE, De Santo LW. Adductor spastic dysphonia: three years after recurrent laryngeal nerve resection. Laryngoscope, 1983, 93: 1-8.
  • 8Isshiki N, Tsuji DH, Yamamoto Y, et al. Midline lateralization thyroplasty for adductor spasmodic dysphonia. Ann Otol Rhinol Laryngol, 2000, 109: 187-193.
  • 9Chan SW, Baxter M, Oates J, et al. Long-term results of type 1I thyroplasty for adductor spasmodic dysphonia. Laryngoscope, 2004, 114: 1604-1608.
  • 10Remacle M, Plouin-Gaudon I, Lawson G, et al. Bipolar radiofrequency-induced thermotherapy (rfitt) for the treatment of spasmodic dysphonia. A report of three cases. Eur Arch Otorhinolaryngol, 2005, 262: 871-874.

二级参考文献26

  • 1杨小菊,李春福.食管上括约肌区神经肌电检查[J].临床耳鼻咽喉科杂志,1994,8(2):84-85. 被引量:3
  • 2徐文,韩德民,侯丽珍,张丽,高玉红,叶京英,王军.痉挛性发音障碍诊断及治疗的研究[J].中华耳鼻咽喉头颈外科杂志,2005,40(4):253-257. 被引量:22
  • 3王丽萍,董晶,陈晓秋,王铁.特发性嗓音震颤的嗓音变化与声学特征分析[J].临床耳鼻咽喉科杂志,2006,20(18):817-819. 被引量:4
  • 4Benninger MS, Gardner G, Grywalski C. Outcomes of botulinum toxin treatment for patients with spasmodic dysphonia. Arch Otolaryngol Head Neck Surg, 2001,127: 1083-1085.
  • 5村野惠美,石毛美代子.痙孿性発声障害の成因と症状///小林武夫.痙孿性発声障害そのメカニズムと治療の現状.東京:時空出版,2000:10-20.
  • 6Capacchione JF, Bodily K, Hudson AJ. Postextubation laryngospasm in a patient with spasmodic dysphonia. Anesthesiology, 2005, 102 : 859-860.
  • 7熊田政信 小林武夫 牧山清 他.痙孿性発声障害の新しぃ評価法:と音筋法モ-テ法[J].音声言語医学,1997,38:88-89.
  • 8牧山清,熊田政信,小林武夫.痙孿性発声障害の新しぃ評価//小林武夫.痙孿性発声障害そのメカニズムと治療の現状.東京:時空出版,2000:21-48.
  • 9Silverman FH. Stuttering and other fluency disorders. 2nd eds. Boston: Allyn & Bacon, 1996.
  • 10林焘,王理嘉.语音学教程.北京:北京大学出版社,1999:9-89.

共引文献30

同被引文献40

  • 1徐文,韩德民,侯丽珍,张丽,高玉红,叶京英,王军.痉挛性发音障碍诊断及治疗的研究[J].中华耳鼻咽喉头颈外科杂志,2005,40(4):253-257. 被引量:22
  • 2杨式麟,何平,吕素清.喉麻痹与喉肌痉挛[J].中华耳鼻咽喉科杂志,1995,30(3):143-145. 被引量:3
  • 3徐文,韩德民,侯丽珍,张丽.声带外侧自体脂肪注射填充术治疗声门闭合不良[J].中国耳鼻咽喉头颈外科,2006,13(7):499-502. 被引量:15
  • 4Muny T. Spasmodic Dysphonia: Let' s Look at That Again. J Voice, 2014, 28 (6) : 694-699.
  • 5Blitzer A, Brin M, Fahn S, et al. The use of Botulinum tox?in in the treatment of focal laryngeal dystonia (spastic Dyspho?nia). Laryngoscope, 1988, 98: 193.
  • 6Chen S. Clinical uses of botulinum neurotoxins: current indi?cations, limitations and future developments. Toxins (Ba?sel) , 2012,4(10): 913-939.
  • 7Novakovic D, Waters HH, D' EliaJB, et al. Botulinum toxin treatment of adductor spasmodic dysphonia: Longitudinal functional outcomes. Laryngoscope, 20 1 1, 1 2 1 ( 3 ) : 606- 612.
  • 8Christy L. Spasmodic Dysphonia: a Laryngeal Control Disor- der Specific to Speech.J Neurosci, 2011 , 31 ( 3 ) : 793- 797.
  • 9Mendelsohn AH, Berke GS. Surgery or Botulinum Toxin for Adductor Spasmodic Dysphonia: A Comparative Study. Ann Otol Rhinol Laryngol, 2012,121(4): 231-238.
  • 10Silverman EP, Garvan C, Shrivastav R, et al. Combined Modality Treatment of Adductor Spasmodic Dysphonia.J Voice, 2012, 26(1): 77-86.

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部